These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31424193)

  • 1. A Novel Bromine-Containing Paroxetine Analogue Provides Mechanistic Clues for Binding Ambiguity at the Central Primary Binding Site of the Serotonin Transporter.
    Slack RD; Abramyan AM; Tang H; Meena S; Davis BA; Bonifazi A; Giancola JB; Deschamps JR; Naing S; Yano H; Singh SK; Newman AH; Shi L
    ACS Chem Neurosci; 2019 Sep; 10(9):3946-3952. PubMed ID: 31424193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics.
    Abramyan AM; Slack RD; Meena S; Davis BA; Newman AH; Singh SK; Shi L
    Neuropharmacology; 2019 Dec; 161():107411. PubMed ID: 30391505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and structural investigation of the paroxetine-human serotonin transporter complex.
    Coleman JA; Navratna V; Antermite D; Yang D; Bull JA; Gouaux E
    Elife; 2020 Jul; 9():. PubMed ID: 32618269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers.
    Rannversson H; Andersen J; Bang-Andersen B; Strømgaard K
    ACS Chem Biol; 2017 Oct; 12(10):2558-2562. PubMed ID: 28910072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
    Nadgir SM; Malviya M
    Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter.
    Chudzik J; McCarthy D; Bakish D; Ravindran A; Hrdina PD
    Biochem Pharmacol; 1995 Oct; 50(8):1211-5. PubMed ID: 7488236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.
    Jin ZL; Chen XF; Ran YH; Li XR; Xiong J; Zheng YY; Gao NN; Li YF
    Sci Rep; 2017 Aug; 7(1):8631. PubMed ID: 28819255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions.
    Plenge P; Wiborg O
    Neurosci Lett; 2005 Aug; 383(3):203-8. PubMed ID: 15955412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species.
    Cupello A; Albano C; Gatta E; Scarrone S; Villa E; Zona G
    Neurochem Res; 2009 Feb; 34(2):255-9. PubMed ID: 18563559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
    Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
    Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for recognition of diverse antidepressants by the human serotonin transporter.
    Coleman JA; Gouaux E
    Nat Struct Mol Biol; 2018 Feb; 25(2):170-175. PubMed ID: 29379174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain.
    Hirano K; Seki T; Sakai N; Kato Y; Hashimoto H; Uchida S; Yamada S
    Brain Res; 2005 Aug; 1053(1-2):154-61. PubMed ID: 16051196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter.
    Davis BA; Nagarajan A; Forrest LR; Singh SK
    Sci Rep; 2016 Apr; 6():23789. PubMed ID: 27032980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter polymorphism and bleeding time during SSRI therapy.
    Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ
    Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
    Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
    J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate and Inhibitor-Specific Conformational Changes in the Human Serotonin Transporter Revealed by Voltage-Clamp Fluorometry.
    Söderhielm PC; Andersen J; Munro L; Nielsen AT; Kristensen AS
    Mol Pharmacol; 2015 Oct; 88(4):676-88. PubMed ID: 26174773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.